GTHP · Guided Therapeutics Inc
$0.21
-0.02 (-6.67%)
At close · Sep 1
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The factors below raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$21.72M
Shares
96.54M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$767K
+10857.1%
FY2025
Net Income
-$3.2M
-32.2%
FY2025
Gross Margin
74.45%
+45.9pp
FY2025
Operating Margin
-309.26%
+29805pp
FY2025
Diluted EPS
-$0.04
+20%
FY2025
Operating Cash Flow
-$1.07M
+4.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $650K | $767K | $7000 | $98K | $13K | $81K | $102K | $36K | $57K | $244K | $0 | $42K | $65K | $820K | $3.34M | $3.6M | $3.36M | |
| $158K | $196K | $5000 | $62K | $81K | $61K | -$41K | $70K | $89K | $530K | $493K | $537K | $891K | $611K | $117K | -$106K | $0 | |
| $492K | $571K | $2000 | $36K | -$68K | $20K | $143K | -$34K | -$32K | -$286K | $112K | $27K | -$133K | -$252K | -$45K | -$81K | — | |
| — | 74.45% | 28.57% | 36.73% | -523.08% | 24.69% | 140.2% | -94.44% | -56.14% | -117.21% | — | 64.29% | -204.62% | -30.73% | -1.35% | -2.25% | — | |
| $341K | $469K | $526K | $228K | $77K | $69K | $143K | $122K | $244K | $334K | $733K | $1.48M | $2.79M | $2.74M | $3.23M | $2.78M | $1.81M | |
| $91K | $169K | $287K | $268K | $181K | $141K | $139K | $87K | $195K | $245K | $393K | $718K | $1.16M | $901K | $424K | $287K | $131K | |
| $2.25M | $2.31M | $1.3M | $3M | $3.01M | $2.17M | $913K | $694K | $1.08M | $2.26M | $2.81M | $4.1M | $4.65M | $3.53M | $3.92M | $3.58M | $3.05M | |
| — | — | — | — | — | — | $0 | $21K | $27K | $213K | $1.22M | $1.05M | $1.24M | $461K | $361K | $34K | — | |
| $2.47M | $2.94M | $2.11M | $3.49M | $3.27M | $2.38M | $1.2M | $903K | $1.52M | $2.84M | $3.93M | $6.3M | $8.6M | $7.17M | $7.57M | $10.27M | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $10.27M | $4.99M | |
| -$1.98M | -$2.37M | -$2.11M | -$3.46M | -$3.33M | -$2.36M | -$1.05M | -$937K | -$1.55M | -$3.12M | -$3.82M | -$6.23M | -$8.67M | -$6.61M | -$4.28M | -$6.76M | -$1.62M | |
| — | -309.26% | -30114.29% | -3527.55% | -25638.46% | -2916.05% | -1031.37% | -2602.78% | -2715.79% | -1279.1% | — | -14826.19% | -13336.92% | -805.61% | -128.25% | -187.82% | -48.19% | |
| — | — | — | — | — | — | -$1.05M | -$916K | -$1.52M | -$2.91M | -$2.6M | -$5.17M | -$7.43M | -$6.15M | -$3.92M | -$6.72M | — | |
| $600K | $617K | $381K | $278K | $582K | $1.15M | $1.06M | $1.41M | $1.76M | $1.11M | $1.9M | $1.32M | $979K | $45K | $72K | $80K | $1.23M | |
| $0 | — | $3000 | $6000 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$1.09M | -$824K | -$309K | -$32K | -$1.01M | $292K | $773K | -$984K | $2.56M | -$7.58M | -$150K | -$675K | — | — | — | — | — | |
| -$3.06M | -$3.2M | -$2.42M | -$3.49M | -$4.34M | -$2.07M | -$279K | -$1.92M | $1.02M | -$10.7M | -$3.97M | -$6.9M | — | — | — | — | — | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | — | |
| -$3.06M | -$3.2M | -$2.42M | -$3.49M | -$4.34M | -$2.07M | -$279K | -$1.92M | $1.02M | -$10.7M | -$3.97M | -$6.9M | -$9.88M | -$7.22M | -$4.35M | -$6.64M | -$2.85M | |
| — | -416.69% | -34528.57% | -3560.2% | -33392.31% | -2555.56% | -273.53% | -5336.11% | 1782.46% | -4383.61% | — | -16433.33% | -15204.62% | -879.88% | -130.41% | -184.71% | -84.6% | |
| -$3.64M | -$3.35M | -$2.59M | -$3.76M | -$4.97M | -$2.43M | -$401K | -$1.92M | $900K | -$10.97M | -$5M | -$9.5M | -$10.04M | -$10.39M | -$4.35M | — | — | |
| USD/shares | -$0.04 | -$0.04 | -$0.05 | -$0.07 | -$0.15 | -$0.18 | -$0.04 | -$0.58 | $1.95 | $997.64 | — | — | — | — | — | — | — |
| USD/shares | -$0.04 | -$0.04 | -$0.05 | -$0.07 | -$0.15 | -$0.18 | -$0.04 | -$0.58 | $0.01 | $0.00 | — | — | — | — | — | — | — |
| shares | — | 78.41M | 57.34M | — | 32.51M | 13.38M | 10.77M | 3302 | 462 | 11 | 203 | 2 | 771 | 65.88K | 57.43K | 48.87K | 38.6K |
| shares | — | 78.41M | 57.34M | 51.13M | 32.51M | 13.38M | 10.77K | 3302 | 65.23K | 0 | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
33.48×
Peer median 1.20×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 68 similar-size Medical Devices companies (of 145 listed).